Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American journal of ophthalmology-glaucoma

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AJO.2005.07.053PMID 16387003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

  2005cited by this paper
• Pegaptanib for neovascular age-related macular degeneration.

  2004cited by this paper
• Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection.

  2004cited by this paper
• Intraocular pressure after intravitreal injection of triamcinolone acetonide

  2003cited by this paper
• Intravitreal triamcinolone and elevated intraocular pressure.

  1999cited by this paper
• Intravitreal triamcinolone and elevated intraocular pressure.

  1999cited by this paper

• The 20th Anniversary of Pegaptanib (MacugenTM), the First Approved Aptamer Medicine: History, Recent Advances and Future Prospects of Aptamers in Therapy

  2025cites this paper
• Evaluation of intraocular pressure and mean ocular perfusion pressure changes following intravitreal anti-VEGF injections

  2025influential citation
• Comparison between two intravitreal injection techniques with respect to fluid reflux, intraocular pressure, and therapeutic effect

  2021cites this paper
• Single transient intraocular pressure elevations cause prolonged retinal ganglion cell dysfunction and retinal capillary abnormalities in mice.

  2020cites this paper
• The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology.

  2019influential citation
• Intraocular pressure changes after repeated ranibizumab injection

  2019cites this paper
• Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells

  2018cites this paper
• Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics

  2018cites this paper
• Hydrogel Formulations for Ophthalmic Delivery

  2017cites this paper
• Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study

  2017cites this paper
• Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure

  2016cites this paper
• Ocular Hypertension Following Intravitreal Antivascular Endothelial Growth Factor Therapy: Review of the Literature and Possible Role of Nitric Oxide

  2016cites this paper
• Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case–control study

  2016cites this paper
• The Effect of Intraocular Pressure Lowering Medications on the Pressure Spike Associated with Intravitreal Injection

  2015cites this paper
• Fluctuation of the Intraocular Pressure during Intravitreal Injection

  2015cites this paper
• ASSOCIATION BETWEEN NEEDLE SIZE, POSTINJECTION REFLUX, AND INTRAOCULAR PRESSURE SPIKES AFTER INTRAVITREAL INJECTIONS

  2015cites this paper
• Comparison of Acetazolamide, Brimonidine, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Initial Intravitreal Bevacizumab Injection: A Randomized Clinical Trial

  2014cites this paper
• İntravitreal Bevacizumab Uygulamasinin erken Dönem Göz İçi Basincina etkisi The Short-Term effect of Intravitreal Bevacizumab Injection on Intraocular Pressure

  2014cites this paper
• Effect of Prophylactic Medication and Influence of Vitreous Reflux in Pressure Rise after Intravitreal Injections of Anti-VEGF Drugs

  2014cites this paper
• Safety Monitoring of Ophthalmic Biologics: A Systematic Review of Pre- and Postmarketing Safety Data

  2014cites this paper
• İntravitreal Bevacizumab Uygulamasının Erken Dönem Göz İçi Basıncına Etkisi

  2014cites this paper
• Persistent elevation of intraocular pressure following intravitreal injection of bevacizumab.

  2013cites this paper
• Incidence and Management of Elevated Intraocular Pressure with Antivascular Endothelial Growth Factor Agents

  2013cites this paper
• The Change of Anterior Chamber Parameters with Pentacam® after Intravitreal Injection

  2013cites this paper
• Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: A Prospective Study

  2012influential citation
• SUSTAINED ELEVATED INTRAOCULAR PRESSURES AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, RANIBIZUMAB, AND PEGAPTANIB

  2011cites this paper
• A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS

  2011cites this paper
• Utilidad en el uso de apraclonidina para el control de la variación de presión intraocular posterior a la aplicación de antiangiogénico intravítreo

  2010cites this paper
• Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application

  2010cites this paper
• Course of Intraocular Pressure after Intravitreal Injection of 0.05 mL Ranibizumab (Lucentis®)

  2010cites this paper
• Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.

  2010cites this paper
• Effect of Brimonidine/Timolol Fixed Combination on Preventing the Short-Term Intraocular Pressure Increase after Intravitreal Injection of Ranibizumab

  2010cites this paper
• [Immediate changes in intraocular pressure after an intravitreal injection of 2.5 mg of bevacizumab].

  2010cites this paper
• Immediate changes in intraocular pressure after an intravitreal injection of 2.5 mg of bevacizumab

  2010cites this paper
• Cambios inmediatos en la presión intraocular después de una inyección intravítrea de 2,5mg de bevacizumab

  2010cites this paper
• ASSESSMENT OF OPTIC NERVE CUP-TO-DISK RATIO CHANGES IN PATIENTS RECEIVING MULTIPLE INTRAVITREAL INJECTIONS OF ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS

  2009cites this paper
• Short-term effect of intravitreal anti-VEGFs delivery on intraocular pressure

  2009cites this paper
• A PROSPECTIVE STUDY OF IN-OFFICE DIAGNOSTIC VITREOUS SAMPLING IN PATIENTS WITH VITREORETINAL PATHOLOGY

  2009cites this paper
• The Effects of Intravitreal Ophthalmic Medications on Intraocular Pressure

  2009cites this paper
• Noninvasive tear meniscometry in dry eye patients with Sjögren syndrome.

  2008cites this paper
• Intraocular Pressure Elevation Following Intravitreal Injection with Antivascular Endothelial Growth Factor

  2008cites this paper
• Évolution des pratiques pour la réalisation des injections intravitréennes

  2008cites this paper
• Rétine et glaucome : implications thérapeutiques

  2008cites this paper
• Intraocular pressure effects of pegaptanib (macugen) injections in patients with and without glaucoma.

  2008cites this paper
• Pharmacotherapy for the treatment of choroidal neovascularization due to age-related macular degeneration.

  2008cites this paper
• [Intravitreous injection: retrospective study on 2028 injections and their side effects].

  2008cites this paper
• [Evolving intravitreous injection technique].

  2008cites this paper
• Intravitreale Injektion

  2008cites this paper
• Short-term intraocular pressure trends after intravitreal injection of bevacizumab (avastin).

  2008cites this paper
• Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.

  2008cites this paper
• Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab

  2007cites this paper
• Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology

  2007cites this paper
• Injection intravitréenne : évaluation rétrospective de la technique et des complications d'une série de 2028 injections

  2007cites this paper
• Intraocular pressure effects of pegaptanib (Macugen) injections in patients with and without glaucoma.

  2007cites this paper
• CHANGES OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN)

  2007cites this paper
• Anti-VEGF Ajanlarda Toksisite-Yan Etkiler Potential Toxicity with Inhibitors of Vascular Endothelial Growth Factor

  2007cites this paper
• Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.

  2006cites this paper
• Pegaptanib in the treatment of wet, age-related macular degeneration

  2006cites this paper
• [(Side) effects of VEGF inhibition].

  2006cites this paper
• (Neben-) Wirkungen der VEGF-Inhibition

  2006cites this paper